Human ovarian carcinoma cells generate CD4+CD25+ regulatory T cells from peripheral CD4+CD25- T cells through secreting TGF-β

Cancer Letters

Volumn 253, Issue 1, 2007, Pages 144-153

  Li, Xiao ^a   Ye, Feng ^a   Chen, Huaizeng ^a   Lu, Weiguo ^a   Wan, Xiaoyun ^a   Xie, Xing ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

CD4+CD25+ regulatory T cell; Foxp3; Ovarian carcinoma; TGF

Indexed keywords

TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; OVARIAN NEOPLASMS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 34249872196     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.01.024     Document Type: Article

References (25)

1. Zou W.P. Immunosuppressive networks in the tumor environment and their therapeutic relevance. Nat. Rev. Cancer 5 (2005) 263-274
2. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162 (1999) 5317-5326
3. + regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol. 14 (2002) 771-778
4. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182 (2001) 18-32
5. + T Cells with regulatory properties from human blood. J. Exp. Med. 193 (2001) 1303-1310
6. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193 (2001) 1285-1294
7. + CD45RB (hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc (Min/+) mice. Cancer Res. 66 (2006) 57-61
8. + regulatory T cell-depleted mice. Cancer Res. 65 (2005) 8471-8478
9. Fecci P.E., Mitchell D.A., Whitesides J.F., et al. Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. Cancer Res. 66 (2006) 3294-3302
10. + regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma. J. Clin. Oncol. 24 (2006) 1169-1177
11. + regulatory T cell in the patients with ovarian carcinoma. Cancer Invest. 23 (2005) 399-403
12. Curiel T.J., Coukos G., Zou L., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10 (2004) 942-949
13. Wolf D., Wolf A.M., Rumpold H., et al. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin. Cancer Res. 11 (2005) 8226-8229
14. + regulatory T cells in human thymus. Nature 436 (2005) 1181-1185
15. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003) 1875-1886
16. + regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. USA 101 (2004) 4572-4577
17. Attisano L., and Wrana J.L. Signal transduction by the TGF-beta superfamily. Science 296 (2002) 1646-1647
18. +regulatory T cells are dependent on CTLA-4 expression. Eur. J. Immunol. 34 (2004) 3485-3496
19. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3 (2002) 135-142
20. + regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc. Natl. Acad. Sci. USA 102 (2005) 6449-6454
21. + T regulatory cells. Nat. Immunol. 4 (2003) 337-342
22. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
23. + regulatory T cells. Int. Immunol. 16 (2004) 1643-1656
24. + regulatory T cells. J. Exp. Med. 201 (2005) 1061-1067
25. Bierie B., and Moses H.L. TGF-beta and cancer. Cytokine Growth Factor Rev. 17 (2006) 29-40